Skip to main content

Loading market data...

ILMN

Illumina, Inc.

NASDAQ • United states

$278.06

+$10.13

(+3.78%)

Source: Yahoo Finance · Quote time Oct 21, 2026 14:47 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Illumina, Inc. (ILMN)

Unavailable

Quotes may be delayed

$41.99B

Market Cap

445,390

Volume

50.9

P/E Ratio

Unavailable

Div Yield

Illumina, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 5200 ILLUMINA WAY, SAN DIEGO, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Oct 2026

Illumina, Inc. reported A material agreement

Illumina, Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

7 Oct 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Illumina, Inc..

18 Aug 2026

Illumina, Inc. reported Another company event

Illumina, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.

14 Aug 2026

Illumina, Inc. reported A material agreement

Illumina, Inc. filed an 8-K covering a material agreement, the end of a material agreement, a material financing obligation, supporting financial statements or exhibits.

12 Aug 2026

Illumina, Inc. reported Another company event

Illumina, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.14B

Total assets (USD)$6.65B

Shareholders' equity (USD)$2.84B

Long-term debt (USD)$673.00M

Debt due within a year (USD)$499.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 28 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.16B	$245.00M	$207.00M	$1.35	10-Q · 31 Jul 2026
Q1 2026	$1.09B	$209.00M	$134.00M	$0.87	10-Q · 4 May 2026
Q4 2025	$1.16B	$202.00M	$334.00M	Unavailable	10-K · 12 Feb 2026
Q3 2025	$1.08B	$227.00M	$150.00M	$0.98	10-Q · 31 Oct 2025
Q2 2025	$1.06B	$214.00M	$235.00M	$1.49	10-Q · 1 Aug 2025
Q1 2025	$1.04B	$164.00M	$131.00M	$0.82	10-Q · 9 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $247.40

-11.0% upside potential

📈

Strong Buy

Unavailable

👍

Buy

9

⏸️

Hold

3

📉

Sell

3

15 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 14:48 UTC Targets range 113.00–320.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

5

Oct 2026

Thaysen Jacob

Director, Chief Executive Officer

Tax withholding

$293.69 per share

1,303 shares

30

Sep 2026

Meister Keith A.

Director

Grant or award

$219.80 per share

107 shares

30

Sep 2026

Ullem Scott B.

Director

Grant or award

$219.80 per share

113 shares

8

Sep 2026

Coletti Julie Ann

Chief Legal Officer

Grant or award

Unavailable per share

18,763 shares

5

Sep 2026

Barnard Steven

SVP, Chief Technology Officer

Tax withholding

$211.06 per share

408 shares

4

Sep 2026

Meister Keith A.

Director

Open-market sale

$218.40 per share

119,501 shares

3

Sep 2026

Meister Keith A.

Director

Open-market sale

$218.23 per share

75,951 shares

2

Sep 2026

Meister Keith A.

Director

Open-market sale

$213.28 per share

68,108 shares

27

Aug 2026

Meister Keith A.

Director

Open-market sale

$228.89 per share

138,379 shares

26

Aug 2026

Meister Keith A.

Director

Open-market sale

$225.46 per share

106,543 shares

Top Shareholders

Blackrock, Inc.

19,191,398 shares

0.882% change

6/30/2026

Capital World Investors

15,425,298 shares

-0.802% change

6/30/2026

Vanguard Group Inc

14,355,380 shares

-1.863% change

12/31/2025

Vanguard Portfolio Management Llc

6,627,157 shares

-2.88% change

6/30/2026

Vanguard Capital Management Llc

6,587,534 shares

-0.111% change

6/30/2026

State Street Corp

6,507,288 shares

1.212% change

6/30/2026

Wcm Investment Management, Llc

6,206,701 shares

4.787% change

6/30/2026

Fmr Llc

4,523,417 shares

192.426% change

6/30/2026

Aqr Capital Management Llc

3,544,465 shares

-10.967% change

6/30/2026

Primecap Management Co/Ca/

3,514,649 shares

70.012% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 14:48 UTC· 16 hours ago

Research coverage and investment tools

Illumina, Inc. (ILMN) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical Specialities). Its last price was US$278.06 on 21 Oct 2026. That is 85% of the way from its 52-week low of US$94.00 to its 52-week high of US$309.35. Its market capitalisation was US$41.99 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.16B	$245.00M	$207.00M	$1.35	66.4%	21.1%	—	10-Q · 31 Jul 2026 (opens in a new tab)
Q1 2026	$1.09B	$209.00M	$134.00M	$0.87	66.1%	19.2%	$251.00M	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$1.16B	$202.00M	$334.00M	Unavailable	65.5%	17.4%	—	10-K · 12 Feb 2026 (opens in a new tab)
Q3 2025	$1.08B	$227.00M	$150.00M	$0.98	67.6%	20.9%	—	10-Q · 31 Oct 2025 (opens in a new tab)
Q2 2025	$1.06B	$214.00M	$235.00M	$1.49	65.6%	20.2%	—	10-Q · 1 Aug 2025 (opens in a new tab)
Q1 2025	$1.04B	$164.00M	$131.00M	$0.82	65.6%	15.8%	$208.00M	10-Q · 9 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/30/2026	$1.31	$1.23	+6.5%
Mar 2026	4/30/2026	$1.15	$1.05	+9.5%
Dec 2025	2/5/2026	$1.35	$1.26	+7.1%
Sep 2025	10/30/2025	$1.34	$1.16	+15.5%

Cash and equivalents: $1.14B
Total assets: $6.65B
Shareholders' equity: $2.84B
Long-term debt: $673.00M
Debt due within a year: $499.00M

8-K · 14 Oct 2026 · Material agreement Signed

Illumina, Inc. reported A material agreement (opens in a new tab)

Illumina, Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.
SCHEDULE 13G · 7 Oct 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Illumina, Inc..
8-K · 18 Aug 2026

Illumina, Inc. reported Another company event (opens in a new tab)

Illumina, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
8-K · 14 Aug 2026 · Material agreement Terminated

Illumina, Inc. reported A material agreement (opens in a new tab)

Illumina, Inc. filed an 8-K covering a material agreement, the end of a material agreement, a material financing obligation, supporting financial statements or exhibits.
8-K · 12 Aug 2026

Illumina, Inc. reported Another company event (opens in a new tab)

Illumina, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Thaysen Jacob Director, Chief Executive Officer	5 Oct 2026	Tax withholding (F)	−1,303	$293.69	Form 4 (opens in a new tab)
Meister Keith A. Director	30 Sep 2026	Grant or award (A)	+107	$219.80	Form 4 (opens in a new tab)
Ullem Scott B. Director	30 Sep 2026	Grant or award (A)	+113	$219.80	Form 4 (opens in a new tab)
Coletti Julie Ann Chief Legal Officer	8 Sep 2026	Grant or award (A)	+18,763	—	Form 4 (opens in a new tab)
Barnard Steven SVP, Chief Technology Officer	5 Sep 2026	Tax withholding (F)	−408	$211.06	Form 4 (opens in a new tab)
Meister Keith A. Director	4 Sep 2026	Open-market sale (S)	−119,501	$218.40	Form 4 (opens in a new tab)
Meister Keith A. Director	3 Sep 2026	Open-market sale (S)	−75,951	$218.23	Form 4 (opens in a new tab)
Meister Keith A. Director	2 Sep 2026	Open-market sale (S)	−68,108	$213.28	Form 4 (opens in a new tab)
Meister Keith A. Director	27 Aug 2026	Open-market sale (S)	−138,379	$228.89	Form 4 (opens in a new tab)
Meister Keith A. Director	26 Aug 2026	Open-market sale (S)	−106,543	$225.46	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	19,191,398	0.882%
Capital World Investors	6/30/2026	15,425,298	-0.802%
Vanguard Group Inc	12/31/2025	14,355,380	-1.863%
Vanguard Portfolio Management Llc	6/30/2026	6,627,157	-2.88%
Vanguard Capital Management Llc	6/30/2026	6,587,534	-0.111%
State Street Corp	6/30/2026	6,507,288	1.212%
Wcm Investment Management, Llc	6/30/2026	6,206,701	4.787%
Fmr Llc	6/30/2026	4,523,417	192.426%
Aqr Capital Management Llc	6/30/2026	3,544,465	-10.967%
Primecap Management Co/Ca/	6/30/2026	3,514,649	70.012%

Previous close: 267.93 USD
Day range: 263.28 – 278.71 USD
52-week range: 94.00 – 309.35 USD
Volume: 445,390
Market cap: $41.99B
Average volume: 2,858,137
P/E ratio: 50.9
EPS (FY 2025, diluted): 5.45 USD
Shares outstanding: 151.00M
Beta (5Y monthly): 1.44

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 14:47 UTC· 16 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:14 UTC· 59 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ILMN yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.